(NYSE: CHE) Chemed's forecast annual revenue growth rate of 4.24% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.56%.
Chemed's revenue in 2025 is $2,488,997,000.On average, 1 Wall Street analysts forecast CHE's revenue for 2025 to be $37,580,803,679, with the lowest CHE revenue forecast at $37,580,803,679, and the highest CHE revenue forecast at $37,580,803,679. On average, 1 Wall Street analysts forecast CHE's revenue for 2026 to be $39,491,414,289, with the lowest CHE revenue forecast at $39,491,414,289, and the highest CHE revenue forecast at $39,491,414,289.
In 2027, CHE is forecast to generate $41,624,393,056 in revenue, with the lowest revenue forecast at $41,624,393,056 and the highest revenue forecast at $41,624,393,056.